Clinical Trial Update: A Study Comparing the Effect and Safety of Linaprazan Glurate to Lansoprazole in Participants With Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing linaprazan glurate to lansoprazole in participants with erosive esophagitis due to GERD is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis
• Gastroesophageal Reflux Disease

Drugs mentioned

• Lansoprazole (Lansoprazole)
• Linaprazan Glurate (linaprazan)

Snippet

Sponsor: Cinclus Pharma Holding AB | Conditions: GERD (Gastroesophageal Reflux Disease) | Phase 3 | Status: ACTIVE_NOT_RECRUITING